Masahiro Hatooka

748 total citations
15 papers, 289 citations indexed

About

Masahiro Hatooka is a scholar working on Hepatology, Pathology and Forensic Medicine and Epidemiology. According to data from OpenAlex, Masahiro Hatooka has authored 15 papers receiving a total of 289 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hepatology, 7 papers in Pathology and Forensic Medicine and 5 papers in Epidemiology. Recurrent topics in Masahiro Hatooka's work include Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Liver Disease Diagnosis and Treatment (5 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). Masahiro Hatooka is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Liver Disease Diagnosis and Treatment (5 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). Masahiro Hatooka collaborates with scholars based in Japan and United Kingdom. Masahiro Hatooka's co-authors include Hiroshi Aikata, Yoshiiku Kawakami, Akira Hiramatsu, Michio Imamura, Kazuaki Chayama, Kei Morio, Tomokazu Kawaoka, Masataka Tsuge, Yuko Nagaoki and Yuki Nakamura and has published in prestigious journals such as Journal of Gastroenterology, Journal of Computer Assisted Tomography and European Journal of Radiology.

In The Last Decade

Masahiro Hatooka

14 papers receiving 280 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Masahiro Hatooka Japan	9	237	129	83	48	37	15	289
Irene Pettinari Italy	10	309 1.3×	210 1.6×	117 1.4×	32 0.7×	11 0.3×	20	436
Hiromasa Katoh Japan	10	100 0.4×	87 0.7×	44 0.5×	9 0.2×	35 0.9×	24	349
Hidekazu Nakagawara Japan	8	189 0.8×	87 0.7×	137 1.7×	10 0.2×	15 0.4×	11	333
Hao-Jan Lei Taiwan	12	252 1.1×	186 1.4×	135 1.6×	21 0.4×	4 0.1×	19	380
Katsuki Danno Japan	8	85 0.4×	40 0.3×	143 1.7×	7 0.1×	21 0.6×	47	292
Vanessa Hebditch United Kingdom	5	204 0.9×	260 2.0×	69 0.8×	19 0.4×	2 0.1×	9	332
Wei‐Fan Hsu Taiwan	12	220 0.9×	193 1.5×	90 1.1×	21 0.4×	2 0.1×	45	365
H. Hokotate Japan	7	213 0.9×	170 1.3×	158 1.9×	14 0.3×	3 0.1×	16	355
Elena Podestà Italy	5	162 0.7×	152 1.2×	54 0.7×	13 0.3×	3 0.1×	6	324
Masashi Tsunematsu Japan	10	47 0.2×	71 0.6×	106 1.3×	10 0.2×	7 0.2×	68	293

Countries citing papers authored by Masahiro Hatooka

Since Specialization

Citations

This map shows the geographic impact of Masahiro Hatooka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masahiro Hatooka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masahiro Hatooka more than expected).

Fields of papers citing papers by Masahiro Hatooka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masahiro Hatooka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masahiro Hatooka. The network helps show where Masahiro Hatooka may publish in the future.

Co-authorship network of co-authors of Masahiro Hatooka

This figure shows the co-authorship network connecting the top 25 collaborators of Masahiro Hatooka. A scholar is included among the top collaborators of Masahiro Hatooka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masahiro Hatooka. Masahiro Hatooka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Uchikawa, Shinsuke, Tomokazu Kawaoka, Hiroshi Aikata, et al.. (2018). Early experience of seven hepatocellular carcinoma cases treated with regorafenib. Clinical Case Reports. 6(11). 2217–2223. 4 indexed citations

Uchikawa, Shinsuke, Tomokazu Kawaoka, Hiroshi Aikata, et al.. (2018). Clinical outcomes of sorafenib treatment failure for advanced hepatocellular carcinoma and candidates for regorafenib treatment in real‐world practice. Hepatology Research. 48(10). 814–820. 33 indexed citations

Kawaoka, Tomokazu, Hiroshi Aikata, Yuji Teraoka, et al.. (2017). Impact of Hepatitis C Virus Eradication on the Clinical Outcome of Patients with Hepatitis C Virus-Related Advanced Hepatocellular Carcinoma Treated with Sorafenib. Oncology. 92(6). 335–346. 11 indexed citations

Nagaoki, Yuko, Hiroshi Aikata, Yuji Teraoka, et al.. (2017). Efficacy and safety of edoxaban for treatment of portal vein thrombosis following danaparoid sodium in patients with liver cirrhosis. Hepatology Research. 48(1). 51–58. 104 indexed citations

Nagaoki, Yuko, Hiroshi Aikata, Yuji Teraoka, et al.. (2017). Risk factors for exacerbation of gastroesophageal varices and portosystemic encephalopathy during treatment with nucleos(t)ide analogs for hepatitis B virus‐related cirrhosis. Hepatology Research. 48(4). 264–274. 3 indexed citations

Teraoka, Yuji, Tomokazu Kawaoka, Hiroshi Aikata, et al.. (2017). Contrast-enhanced ultrasonography using Sonazoid for the diagnosis of cholangiolocellular carcinoma. Kanzo. 58(12). 654–663.

Kawaoka, Tomokazu, Hiroshi Aikata, Yuki Inagaki, et al.. (2017). Enhanced ultrasonography detection of mucosa-associated lymphoid tissue of the liver with penetrating vessels in a tumor -case report. Kanzo. 58(5). 280–288. 4 indexed citations

Kobayashi, Tomoki, Hiroshi Aikata, Fumi Honda, et al.. (2016). Preoperative Fluorine 18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Prediction of Microvascular Invasion in Small Hepatocellular Carcinoma. Journal of Computer Assisted Tomography. 40(4). 524–530. 39 indexed citations

Morio, Reona, Hideyuki Hyogo, Masahiro Hatooka, et al.. (2016). The risk of transient postprandial oxyhypoglycemia in nonalcoholic fatty liver disease. Journal of Gastroenterology. 52(2). 253–262. 8 indexed citations

10.

Honda, Yohji, Hiroshi Aikata, Fumi Honda, et al.. (2016). Clinical outcome and prognostic factors in hepatocellular carcinoma patients with bone metastases medicated with zoledronic acid. Hepatology Research. 47(10). 1053–1060. 12 indexed citations

11.

Nakano, Norihito, Tomokazu Kawaoka, Hiroshi Aikata, et al.. (2016). Complete response to short‐term sorafenib treatment alone for hepatocellular carcinoma with bone, lymph node, and peritoneum metastases. Hepatology Research. 46(13). 1402–1408. 3 indexed citations

12.

Nakamura, Yuki, Hiroshi Aikata, Takayuki Fukuhara, et al.. (2016). Liver fibrosis assessment by FibroScan compared with pathological findings of liver resection specimen in hepatitis C infection. Hepatology Research. 47(8). 767–772. 14 indexed citations

13.

Fukuhara, Takayuki, Hiroshi Aikata, Hideyuki Hyogo, et al.. (2015). Efficacy of radiofrequency ablation for initial recurrent hepatocellular carcinoma after curative treatment: Comparison with primary cases. European Journal of Radiology. 84(8). 1540–1545. 14 indexed citations

14.

Kawaoka, Tomokazu, Hiroshi Aikata, Hideyuki Hyogo, et al.. (2015). Comparison of hepatic arterial infusion chemotherapy versus sorafenib monotherapy in patients with advanced hepatocellular carcinoma. Journal of Digestive Diseases. 16(9). 505–512. 37 indexed citations

15.

Waki, Koji, Keiji Tsuji, Daiki Hirano, et al.. (2014). [A case report of hepatocellular carcinoma with metastases to the lip, stomach, and colorectum].. PubMed. 111(3). 535–42. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact